聯合健康集團UNH
紐約證券 · USD
408.52
+2.97
(+0.73%)
收盤 06/13 04:00 (UTC+8)
盤後
408.94
+0.42
(+0.10%)
06/13 04:00 (UTC+8)
聯合健康集團UNH
408.52
+2.97
(+0.73%)
財務數據
損益表
- 944.27
- 997.96
- 988.55
- 1008.20
- 1008.07
- 1095.75
- 1116.16
- 1131.61
- 1132.15
- 1117.21
- 2.24
- 5.69
- -0.94
- 1.99
- -0.01
- 8.70
- 1.86
- 1.38
- 0.05
- -1.32
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | 111,721,000 | 113,215,000 | 113,161,000 | 111,616,000 | 109,575,000 | 100,807,000 | 100,820,000 | 98,855,000 | 99,796,000 | 94,427,000 |
營業成本 | 73,489,000 | 82,041,000 | 79,958,000 | 78,585,000 | 73,411,000 | 67,035,000 | 65,957,000 | 65,458,000 | 65,735,000 | 62,231,000 |
營業毛利 | 38,232,000 | 31,174,000 | 33,203,000 | 33,031,000 | 36,164,000 | 33,772,000 | 34,863,000 | 33,397,000 | 34,061,000 | 32,196,000 |
營業費用 | 29,242,000 | 30,794,000 | 28,888,000 | 27,881,000 | - | - | - | - | 26,130,000 | 24,507,000 |
研發費用 | - | - | - | - | - | - | - | - | - | - |
推銷及管理費用 | - | - | - | - | - | - | - | - | - | - |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 29,242,000 | 30,794,000 | 28,888,000 | 27,881,000 | 27,045,000 | 25,999,000 | 26,155,000 | 25,522,000 | 26,130,000 | 24,507,000 |
營業利益 | 8,990,000 | 380,000 | 4,315,000 | 5,150,000 | 9,119,000 | 7,773,000 | 8,708,000 | 7,875,000 | 7,931,000 | 7,689,000 |
其他收入及費用 | -72,000 | -126,000 | -83,000 | -41,000 | -15,000 | 21,000 | -20,000 | -1,225,000 | -7,086,000 | - |
利息費用 | 955,000 | 974,000 | 1,003,000 | 1,027,000 | 998,000 | 1,003,000 | 1,074,000 | 985,000 | 844,000 | 830,000 |
稅前純益 | 7,963,000 | -720,000 | 3,229,000 | 4,082,000 | 8,106,000 | 6,791,000 | 7,614,000 | 5,665,000 | 1,000 | 6,859,000 |
所得稅 | 1,482,000 | -938,000 | 686,000 | 510,000 | 1,632,000 | 1,007,000 | 1,356,000 | 1,244,000 | 1,222,000 | 1,184,000 |
稅後純益 | 6,280,000 | 10,000 | 2,348,000 | 3,406,000 | 6,292,000 | 5,543,000 | 6,055,000 | 4,216,000 | -1,409,000 | 5,455,000 |
基本每股稅後盈餘(元) | 6.92 | 0.01 | 2.59 | 3.76 | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 |
稀釋每股稅後盈餘(元) | 6.90 | 0.02 | 2.59 | 3.74 | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 |
基本平均股數(千股) | 907675.00 | 905838.00 | 905673.00 | 905000.00 | 910000.00 | 915000.00 | 930107.00 | 921000.00 | 920000.00 | 924000.00 |
稀釋平均股數(千股) | 910000.00 | 910000.00 | 908000.00 | 910000.00 | 918000.00 | 927000.00 | 930107.00 | 928000.00 | 922000.00 | 935000.00 |
還原基本每股稅後盈餘(元) | 6.92 | 0.01 | 2.59 | 3.76 | 6.91 | 6.06 | 6.51 | 4.58 | -1.53 | 5.90 |
還原稀釋每股稅後盈餘(元) | 6.90 | 0.02 | 2.59 | 3.74 | 6.85 | 5.98 | 6.51 | 4.55 | -1.53 | 5.85 |
還原基本平均股數(千股) | 907,675 | 905,838 | 905,673 | 905,000 | 910,000 | 915,000 | 930,107 | 921,000 | 920,000 | 924,000 |
還原稀釋平均股數(千股) | 910,000 | 910,000 | 908,000 | 910,000 | 918,000 | 927,000 | 930,107 | 928,000 | 922,000 | 935,000 |
EBITDA(千元) | 9,746,000 | 1,163,000 | 5,136,000 | 6,027,000 | 9,983,000 | 8,594,000 | 9,526,000 | 7,465,000 | 1,654,000 | 8,443,000 |